19 August 2026
Latham & Watkins Advises LEO Pharma in Acquisition of Worldwide Rights to MC1R Agonist Dersimelagon
Advising firms
Deal team
28 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| David Brown Lead | Latham & Watkins LLP | Partner | corporate | Washington, D.C. |
| Marc Granger Lead | Latham & Watkins LLP | Partner | corporate | Washington, D.C. |
| Patrick Loeffler | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jane Lee | Latham & Watkins LLP | Associate | corporate | Not stated |
| Aaron Gardner | Latham & Watkins LLP | Partner | licensing | New York |
| Oliver Mobasser | Latham & Watkins LLP | Counsel | licensing | London |
| Eliot Choy | Latham & Watkins LLP | Counsel | licensing | New York |
| Luke Nauth | Latham & Watkins LLP | Associate | licensing | Not stated |
| Roger Chin | Latham & Watkins LLP | Partner | intellectual property | Bay Area |
| Cecilia Bain | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA | Washington, D.C. |
| Caroline Kessler | Latham & Watkins LLP | Associate | FDA | Not stated |
| Matthew Conway | Latham & Watkins LLP | Partner | executive compensation and benefits | Washington, D.C. |
| Rebecca Fishbein | Latham & Watkins LLP | Associate | executive compensation and benefits | Not stated |
| Andrea Ramezan-Jackson | Latham & Watkins LLP | Partner | tax | Washington, D.C. |
| Eni Kassim | Latham & Watkins LLP | Associate | tax | Not stated |
| Amanda Reeves | Latham & Watkins LLP | Partner | HSR | Washington, D.C. |
| Patrick English | Latham & Watkins LLP | Partner | HSR | Washington, D.C. |
| Nathaniel Amann | Latham & Watkins LLP | Associate | HSR | Not stated |
| Suhansi Perera | Latham & Watkins LLP | Associate | HSR | Not stated |
| Jana Dammann de Chapto | Latham & Watkins LLP | Partner | foreign direct investment | Hamburg |
| Nicolas Riemann | Latham & Watkins LLP | Associate | foreign direct investment | Not stated |
| Jim Barker | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Andrew Galdes | Latham & Watkins LLP | Partner | export controls and sanctions | Washington, D.C. |
| Ankita Satpathy | Latham & Watkins LLP | Associate | export controls and sanctions | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy and cybersecurity | Bay Area |
| Zac Alpert | Latham & Watkins LLP | Associate | data privacy and cybersecurity | Not stated |
| Aaron Potash | Latham & Watkins LLP | Partner | environmental | Los Angeles |
25 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- LEO PharmaBuy-side
- Counterparties
- Tanabe Pharma (Sell-side)